CONGENITAL HYDROCEPHALUS AND HEMIVERTEBRAE ASSOCIATED WITH DE NOVO PARTIAL MONOSOMY 6q (6q25.3→qter)
Li Y, Choy K-W, Xie H-N, Chen M, He W-Y, Gong Y-F, Liu H-Y, Song Y-Q, Xian Y-X, Sun X-F, Chen X-J,
*Corresponding Author: Xin-Jie Chen, Ph.D., Key Laboratory of Reproductive Medicine of Guangdong Province, Key Laboratory for Major Obstetric Diseases of Guangdong Province, Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, The Third Affiliated Hospital of Guangzhou Medical University, Duobao Road 63, Guangzhou, 510150, Guangdong, People’s Republic of China. Tel: +86-20-81292292. Fax: +86-20-81292013. E-mail: lucychen23@aliyun.com
page: 77

DISCUSSION

Hemivertebrae is a rare congenital spinal malformation in which only one side of the vertebral body develops, leading to a secondary deformation of the spine, such as scoliosis or kyphosis [7,10]. The condition is found in five to ten per 10,000 births, occurring more commonly in girls [9]. Hemivertebrae may exist alone, but more commonly, hemivertebrae occur with multiple congenital abnormalities, such as skeletal anomalies of the spine, ribs, and limbs; diastematomyelia; cardiac system and genitourinary tract anomalies; and central nervous system (CNS), deformities, either in prenatally or postnatally diagnosed cases [6-10]. Notably, hemivertebrae may be involved in several genetic syndromes, including Jarcho-Levin syndrome, Klippel-Feil syndrome and VATER syndrome (vertebral anomalies, imperforate anus, tracheoesophageal fistula, and renal anomalies) [6,12]. The etiology of hemivertebrae is not clear because it usually occurs sporadically; thus the likelihood of genetic involvement has been considered low. Several chromosome deletions associated with hemivertebrae have previously been reported in earlier studies. These deletions include del(1q4), del(3p2), monosomy 4p, interstitial 5qdeletion, r(15) and interstitial deletion of 17p [13]. However, more recent studies have shown that the correlation between hemivertebra and chromosomal abnormalities is small. Fetal karyotypes are usually normal whether the hemivertebrae are isolated or non isolated, although non isolated hemivertebrae may be associated with an increased risk of aneuploidy [7,12]. Therefore, the complexity and uncertainty of the cause of hemivertebrae contribute to the difficulty of interpreting the genotype-phenotype correlations in our case. With regard to hemivertebrae associated with 6q terminal deletion, hemivertebrae generally emerges as a deformity accompanying major anomalies associated with 6q subtelomeric deletions. Nevertheless, the 6q terminal region has never been considered as a candidate chromosomal region that could be responsible for hemivertebrae, and the underlying genotype-phenotype correlations require further investigation. The T (also known as Brachyury) gene that maps to 6q27 encodes a transcription factor that is essential for normal mesodermal development and the formation and differentiation of the notochord in all vertebrates. The notochord controls cell migration and differentiation in those tissues that are most often involved in sacral agenesis, the neural tube, and the sclerotomal cells that form the vertebrae. In mice, mutations of the T gene lead to the lack of expression of the product and have been recognized as the cause of dominant Brachyury and death in utero, with an abnormal notochord and absent somites. The T gene has been proposed as a candidate gene for sacral agenesis in humans. Furthermore, a previous study of congenital vertebral malformations (CVMs) indicated that missense mutations in the T gene might result in the pathogenesis of human CVMs as one of the genetic components [14]. The CVMs are a class of disorders composed of hemivertebrae, vertebral bars, supernumerary vertebrae, and butterfly- and wedgeshaped vertebrae. Although there is no evidence addressing the direct correlation between the T gene and hemivertebrae, taken together, it is possible that copy number loss resulting from haploinsufficiency of this gene might have substantially contributed to the hemivertebrae malformation observed in our case. Congenital hydrocephalus can occur as an isolated abnormality or in combination with many genetic syndromes, referred to as multiple congenital anomalies (MCAs), in various body systems [15,16]. The main clinical sign in most fetuses with congenital hydrocephalus is cerebral ventriculomegaly [16], which is a pathological dilatation of the cerebral ventricular system and might be a consequence of obstruction of the flow of cerebral spinal fluid (CSF), hyper-secretion, defective filtration or a developmental anomaly of the intracranial architecture [5]. To date, the specific causes of congenital hydrocephalus in the majority of cases remain under investigation. Garne et al. [17] recently demonstrated that 87 fetuses and infants with congenital hydrocephalus exhibited a low rate of karyotype anomalies (9.0%). However, evidence from previous studies suggests that the genetic etiology probably plays an important role in congenital hydrocephalus. Indeed, approximately 40.0% of cases of congenital hydrocephalus may be attributable to genetic factors, including cytogenetic abnormalities, monogenic or complicated inherited conditions and multifactorial disorders [17], although non syndromic hydrocephalus appears to be less related to these conditions. Based on the literature, except for the most common cytogenetic abnormalities such as aneuploid and multiploid karyotypes, submicroscopic chromosomal aberrations, also known as genomic CNVs, represent an important genetic cause in a growing number of cases. The variant regions in most chromosomes have been previously described. In particular, 6p terminal deletions have been rather frequently reported to be associated with congenital hydrocephalus. However, most previous reports were based on syndromic hydrocephalus (≥1 major and >2 minor anomalies), and non syndromic (no major and ≤2 minor anomalies) cases have rarely been described. In addition, few studies have elucidated the molecular basis of the disease phenotype or the relationship between the CNVs and phenotypic characteristics. In the present study, the proband exhibited features that are known to be associated with the terminal 6q deletion phenotype. This fetus presented bilateral hydrocephalus/ ventriculomegaly and a lumbar hemivertebrae but lacked the typical phenotypic features of subtelomeric 6q deletion, such as developmental delay, corpus callosum anomalies, microcephaly, cleft palate and hyperactivity [2,3,5], which was considered unusual for such a large deletion, spanning 10.04 Mb. Until now, very few cases of prenatal ventriculomegaly due to submicroscopic terminal 6q deletions have been reported, and in those cases, the extent of the deletion with respect to non syndromic ventriculomegaly was less than 5 Mb [5,18]. For postnatal cases, Lee et al. [3] made a comprehensive summary of 28 patients diagnosed postnatally with subtelomeric 6q deletions of ≤11 Mb and idiopathic intellectual disability, developmental delay and/ or dysmorphic features. These authors reported that smaller 6q terminal deletions tended to cause milder anomalies. Accordingly, we speculated that the size of the deletion appears to be correlated with the clinical complexity of the phenotype. Thus, the fetus in our study should have more severe malformations and more types of abnormalities because the deleted region held more functional genes that could contribute to the clinical manifestation. However, it is more likely that several specific genes located within the deleted segment play a role in the genesis of hydrocephalus. The TBP gene is most frequently mentioned in relation to the 6q terminal deletion phenotype [3,5,18-20]. This gene encodes a TATA-binding protein, which is a subunit of the RNA polymerase II transcription factor that affects the initiation of transcription. It has been found to be highly expressed in the cerebral cortex, the frontal, parietal and occipital lobes and the caudate nucleus, and it has an important role in CNS morphogenesis [19,20]. Deletion of TBP may affect the elaboration of cortical neurons, and cortical maldevelopment could contribute to mental retardation and seizures, which are commonly seen in patients with 6q terminal deletions [20]. Moreover, dynamic mutations that expand the CAG trinucleotide repeat in the TBP gene have been identified to cause spinocerebellar ataxia 17, a neurodegenerative disorder [3]. However, there is no definite proof to verify the correlation between the TBP gene and hydrocephalus. Nonetheless, because a portion of the cases of congenital hydrocephalus result from brain deformity, we hypothesize that haploinsufficiency of TBP, which might cause cortical dysplasia, could be responsible for congenital hydrocephalus. The PSMB1 gene is a multicatalytic protease complex with a highly ordered ring-shaped 20S core structure that is situated next to the TBP gene both in humans and mice. The PSMB1 gene is tightly associated with TBP as a functional unit in both species. On this basis, PSMB1 and TBP appear to have similar genetic, functional and pathological features [20]. Thus, we suggest that PSMB1 and TBP may be additional candidate genes for the congenital hydrocephalus phenotype associated with the terminal 6q deletion. Recently, the Quaking (QKI) gene that maps to 6q26 has been proposed to be associated with the clinical phenotype of the 6q terminal deletion [3,21]. In humans, Aberg et al. [22] demonstrated that downregulation of the QKI gene might cause a decline in the mRNA levels of the myelin-related genes (PLP1, MAG, and TF) that are involved in oligodendrocyte differentiation and maturation in 55 schizophrenic patients when compared with the controls, thus indicating that QKI may play a role in myelin and oligodendrocyte dysfunction in schizophrenia. In addition, Backx et al. [21] reported the disruption of the QKI gene in association with a de novo balanced translocation resulting in a clinical phenotype similar to the common subtelomeric 6q deletion syndrome, though without seizures and brain anomalies. This result suggests that haploinsufficiency of the QKI gene underlies a substantial part of the 6q subtelomeric deletion phenotype. Deletion of QKI leads to dysmyelination defects, and deletion of PARK2 co-regulated (Pacrg)contributes to mild hydrocephalus [23]. Furthermore, the communicating hydrocephalus phenotype can be rescued by the transgenic expression of Pacrg in the qkv mutant. Considering that the structure and function of cilial systems is highly conserved between humans and mice, we suggest that haploinsufficiency of the human Pacrg gene located at 6q26 is responsible for the congenital hydrocephalus phenotype. A recent article reported that the smallest region of overlap spans 1.7 Mb in 6q27 and contained DLL1, THBS2, PHF10, and C6orf70 (ERMARD), which are plausible candidates for the causation of structural brain abnormalities [24]. DLL1 is expressed in the paraxial mesoderm, which is correlated with somito genesis in the nervous system [25]. PHF10 encoding a zing finger domain protein is essential for self-renewal of the multipotent neural stem cells and neuronal differentiation [24]. But the relationship between these candidate genes and CNS abnormalities is not sure, and the underlying pathogenicity is not known. Maybe the molecular basis of these genes for the disorder will be studied in the future. So here we hypothesize the genes to be candidate genes. A recent article reported seven patients and reviewed 14 patients in previous literature [24]. Here we review 6q terminal deletion patients reported with hydrocephalus and hemivertebrae present in DECIPHER (Figure 5). From this figure, we can find the patients who have the same phenotype as ours. Moreover, their genotype in the 6q terminal deletion is partially or totally similar to ours. So these can nicely illustrate the deletion region that is responsible for our patient’s phenotype. In summary, we present a prenatal diagnosis of a de novo partial monosomy 6q(6q25.3→qter) by aCGH using uncultured amniocytes from a fetus with congenital hydrocephalus and hemivertebrae. To the best of our knowledge, this report describes the largest detection of submicroscopic 6q terminal deletions because of an atypical prenatal finding of ventriculomegaly and hemivertebrae. We performed a detailed investigation of the genotype-phenotype correlations of the plausible candidate genes TBP, PSMB1, QKI, Pacrg, and T with hydrocephalus and hemivertebrae. Further investigation is required to clarify the genetic mechanisms of the genes responsible for the phe-notypic effects. Declaration of Interest. This study was supported by the grants from Guangdong Higher Education Institutes of Science and the Technology Innovation Project (2012 KJCX0087). The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006